Tagged with R

Malaysia Lance Duan, general manager of Roche Malaysia, discusses the dynamic changes in the country’s health system and the possibilities that exist for Roche to establish a collaborative relationship with the new government. Duan also describes the many initiatives Roche has to support Malaysian patients from a varying degree of angles,…

Turkey Emin Çakmak, chairman of the Turkish Healthcare Travel Council, offers deep insights into the healthcare travel industry and how it stretches beyond the commonly used term of “medical tourism”. Çakmak also elaborates on the current dynamics of the industry in Turkey, the features that have made the country a choice…

France Jacques Vernin, president of FACOPHAR Santé – the French association representing companies involved in the natural and herbal health space, explains its role and the future of the organization in participating in social dialogue, shaping regulations and promoting French excellence in the field of herbal ingredients.   Could you please…

Turkey Elif Çelik, executive vice president of the Healthcare Division of Eczacıbaşı Group, explains the rationale behind the group’s divestment of its generics arm and its new strategy to establish itself as a holistic healthcare organization, focused on bringing innovative solutions to Turkey through diverse partnership opportunities. Çelik also discusses the…

France Prof. Alexis Brice, director of the French Brain & Spine Institute (Institut du Cerveau et de la Moelle épinière (ICM)), reveals the recipe behind the success of the center since its foundation eight years ago and discusses the future of research on neurodegenerative diseases.   Could you please introduce your…

Algeria Haissam Chraiteh, country chair for Sanofi Algeria, expands on Sanofi’s ground-breaking foothold in Algerian local production, and how its partnership with the authorities ultimately manifests itself in better provision for patients.   What are your impressions of the Algerian market after two years here as country chair for Sanofi Algeria?…

Malaysia Dr. Saunthari Somasundaram walks us through the NCSM’s mission to raise awareness on cancer prevention and early diagnosis in Malaysia. She details the need for more government support to make cancer education a pillar in healthcare and discredits the idea that care only includes treatment and cure.   Could you…

Algeria Multinational pharmaceutical companies are increasingly choosing Algeria as a base for their regional headquarters, despite the complexities of the local market. The representatives of Lilly, bioMérieux and Abbott in Algeria tell us why. As geographically the largest country in Africa, Algeria stands out, as does its universal healthcare system which bears…

Hong Kong Yvette Chu, general manager of CooperVision Hong Kong, shares the affiliate’s double-digit growth over the past three years, the importance of their relationships with the optometrists in Hong Kong, the value of their innovative and comprehensive portfolio of contact lenses, and her vision for the affiliate in the next few…

France Emmanuel Eumont, general manager of Gedeon Richter France, discusses the group’s leading position in women’s health, its external growth strategy, notably through the acquisition of Finox Biotech in 2016, and the upcoming product launches that will strengthen its portfolio. Finally, Eumont shares his thoughts on the 8th edition of the…

Europe European countries ranked by the levels of generics penetration within their domestic markets. Poland comes out on top by this measurement, with generic medicines making up a full 60.4% of market sales value, followed closely by Russia and Italy. At the other end of the scale, generics make up just…

UK Yesterday, pharma giant AstraZeneca announced that they have halted investment in the UK due to lack of clarity on trading regulations during this time of Brexit uncertainty. “If a transition deal does not make clear what will happen in the future, we will maintain our decision not to invest,” Leif…